Koninklijke DSM N.V. (DSM.AS) Comparison with companies in other sectors?

Koninklijke DSM N.V. has a share price of 6.70M. You can analyze Koninklijke DSM N.V. (DSM.AS) competitors across different market sectors through stock heatmaps.

What are DSM.AS's NET and operating margins?

Koninklijke DSM N.V. (DSM.AS) operating margin is around 0.22, and net profit margin is approximately 0.06 as of the latest reports.

In what way does DSM.AS's earnings per share (EPS) trend reflect its financial momentum?

Koninklijke DSM N.V. (DSM.AS) EPS is 6.25 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Koninklijke DSM N.V. is 18.25, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Koninklijke DSM N.V.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Koninklijke DSM N.V. like P/E which is 41.69, P/B which is 1.96, and PEG which is 0.42. Compare them with sector averages to evaluate if the stock is priced fairly.

Koninklijke DSM N.V.

DSM.AS•EURONEXT

Basic Materials

Chemicals - Specialty

€114.05

€0.00(0.00%)

Fundamental Analysis of Koninklijke DSM N.V. (DSM.AS)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$6.25

P/E Ratio

18.25

ROE

0.05%

Net Margin

0.06%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$763.73M

Shares OutstandingTotal number of shares issued

$6.70M

Book Value/ShareNet worth per share

$-37.77

Revenue/ShareAnnual revenue per share

$48.32

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$6.25

Net MarginNet income as percentage of revenue

5.66%

Operating MarginOperating income as percentage of revenue

21.64%

ROEReturn on shareholders' equity

4.89%

ROAReturn on total assets

ROCEReturn on capital employed

-70.39%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$2.64

Cash/ShareCash and equivalents per share

$16.59

FCF YieldFree cash flow as percentage of market cap

60.10%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for DSM.ASFinancial Ratios Analysis details for DSM.AS are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for DSM.ASSector Benchmarking details for DSM.AS are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Koninklijke DSM N.V. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Koninklijke DSM N.V.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Koninklijke DSM N.V.'s unique business strengths and challenges.

Key Financial Metrics for Koninklijke DSM N.V.

For Koninklijke DSM N.V., essential financial indicators include EPS 6.25, PE 18.25, and ROE 0.05. These key ratios reveal insights into Koninklijke DSM N.V.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare Koninklijke DSM N.V. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Koninklijke DSM N.V.

Metrics like Net Margin 5.66% and ROA - shed light on how well Koninklijke DSM N.V. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Koninklijke DSM N.V. can sustain its operations and continue growing in the future.

Valuation and Market Position of Koninklijke DSM N.V.

Using ratios such as P/B Ratio 1.96 and PEG Ratio 0.42, investors can assess whether Koninklijke DSM N.V. is appropriately valued based on its financials and growth potential. These figures, combined with Koninklijke DSM N.V.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Koninklijke DSM N.V.

Financial health indicators, such as Debt/Equity Ratio - and Cash Flow $2.64, provide a snapshot of Koninklijke DSM N.V.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Koninklijke DSM N.V., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Koninklijke DSM N.V.

Investing in Koninklijke DSM N.V. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Koninklijke DSM N.V. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;